307 related articles for article (PubMed ID: 8962278)
21. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
[TBL] [Abstract][Full Text] [Related]
22. Allograft instability with frequent acute rejections and early chronic transplant glomerulopathy related to suboptimal doses of cyclosporine A.
Savin M; Petronic V; Djukanovic L; Dujic A; Stojkovic D; Sindjic M
Transplant Proc; 1997 Nov; 29(7):2977-9. PubMed ID: 9365636
[No Abstract] [Full Text] [Related]
23. Chronic rejection in cyclosporin A treated renal allograft recipients with allopeptide reactive T cells.
Iniotaki-Theodoraki A; Boletis J; Stamatiadis D; Choremi H; Kostakis A
Transplant Proc; 1999; 31(1-2):1168-70. PubMed ID: 10083522
[No Abstract] [Full Text] [Related]
24. Effect of anti CD45 on different immunosuppressive regimes in renal transplantation.
Talbot D; Shenton BK; Bell A; White M; Glennon A; Manas D; Minford E; Rix D; Mathew A; Kumar A; Taylor RM
Transplant Proc; 1996 Dec; 28(6):3212-3. PubMed ID: 8999605
[No Abstract] [Full Text] [Related]
25. The effect of donor age on kidney graft function and on histopathological findings.
Isoniemi H; von Willebrand E; Krogerus L; Taskinen E; Ahonen J; Häyry P
Transplant Proc; 1992 Feb; 24(1):328-9. PubMed ID: 1539296
[No Abstract] [Full Text] [Related]
26. Abbreviated AUC monitoring of cyclosporine more adequately identified patients at risk for acute rejection during induction of immunosuppressive therapy after kidney transplantation than recommended C2 concentration values.
Troncoso P; Ortiz AM; Jara A; Vilches S
Transplant Proc; 2009; 41(1):127-30. PubMed ID: 19249495
[TBL] [Abstract][Full Text] [Related]
27. Immunoglobulin i.v. high dose (IVIgHD): new therapy as a rescue treatment of grafted kidneys.
Casadei D; Rial M; Raimondi E; Goldberg J; Argento J; Haas E
Transplant Proc; 1996 Dec; 28(6):3290-1. PubMed ID: 8962275
[No Abstract] [Full Text] [Related]
28. Effect of early cyclosporine levels on kidney allograft rejection.
Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
[TBL] [Abstract][Full Text] [Related]
29. Preoperative induction therapy with oral cyclosporine for recipients of living-related renal transplants.
Rudich SM; Bhaduri S; Chang T; Cahn J; Katznelson S; Perez RV
Transplant Proc; 1998 Jun; 30(4):1339-42. PubMed ID: 9636545
[No Abstract] [Full Text] [Related]
30. Kidney transplantation: generic HLA DR compatibility reduces acute rejection episodes.
Reviron D; Mercier P; Jaber K; Dussol B; Brunet P; Berland Y
Transplant Proc; 1996 Oct; 28(5):2812-3. PubMed ID: 8908073
[No Abstract] [Full Text] [Related]
31. Effect of HLA matching on graft survival in live donor kidney transplantations.
Velidedeoğlu E; Bilgin N; Haberal M
Transplant Proc; 1993 Dec; 25(6):3144-5. PubMed ID: 8266491
[No Abstract] [Full Text] [Related]
32. Tubular effects of cyclosporine in pediatric renal transplant recipients.
Laine J; Holmberg C
Transplant Proc; 1996 Aug; 28(4):2104-6. PubMed ID: 8769167
[No Abstract] [Full Text] [Related]
33. Insensitivity to cyclosporine may explain the HLA-DRw6 recipient effect.
Kudlacek S; Zlabinger GJ; Pohanka E; Hamilton G; Rosenmayr A; Kovarik J
Transpl Int; 1992; 5 Suppl 1():S556-8. PubMed ID: 14621875
[TBL] [Abstract][Full Text] [Related]
34. Influence of matching for HLA-DR in first cadaveric renal transplantation in nonsensitized recipients.
Reisaeter AV; Leivestad T; Fauchald P; Brekke I; Thorsby E
Transplant Proc; 1997 Nov; 29(7):3099-100. PubMed ID: 9365682
[No Abstract] [Full Text] [Related]
35. Delayed graft function is associated with an increased incidence of occult rejection and results in poorer graft survival.
Howard RJ; Pfaff WW; Brunson ME; Ramos EL; Peterson JC; Croker BP; Scornik JC; Parris CJ; Fennell RS
Transplant Proc; 1993 Feb; 25(1 Pt 2):884. PubMed ID: 8442256
[No Abstract] [Full Text] [Related]
36. Kidney transplantation in elderly patients.
Pretagostini R; Berloco P; Poli L; Rossi M; Caricato M; Casciaro G; Cocciolo P; Colonnello M; Venettoni S; Bruzzone P; Novelli G; Alfani D; Cortesini R
Transplant Proc; 1996 Feb; 28(1):192-3. PubMed ID: 8644174
[No Abstract] [Full Text] [Related]
37. Reduced incidence of chronic rejection in cyclosporine-treated solid organ recipients with donor antigen-specific hyporeactivity.
Reinsmoen NL; Hertz MI; Kubo SH; Bolman RM; Matas AJ
Transplant Proc; 1994 Oct; 26(5):2558-9. PubMed ID: 7940790
[No Abstract] [Full Text] [Related]
38. Application of corbrin capsule in human renal transplantation.
Min Z; Oi J; Zhu Y; Wei W
Transplant Proc; 1996 Jun; 28(3):1626-8. PubMed ID: 8658813
[No Abstract] [Full Text] [Related]
39. Immunological analysis of kidney allograft infiltrates during rejection: presence of cells coexpressing CD4 and CD8 antigens.
Trovati A; Cinti P; Tamburro ML; Lattanzi R; Baiano V; Orlandini AM; Renna Molajoni E; Cortesini R
Transplant Proc; 1995 Feb; 27(1):930-1. PubMed ID: 7879236
[No Abstract] [Full Text] [Related]
40. Hyperamylasemia in kidney transplant recipients.
Yokoyama I; Hayashi S; Kobayashi T; Negita M; Katayama A; Nagasaka R; Namii Y; Kojima T; Koike C; Uchida K; Takagi H
Transplant Proc; 1996 Jun; 28(3):1476-7. PubMed ID: 8658748
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
